To access the full text documents, please follow this link: http://hdl.handle.net/2445/120991
dc.contributor | Universitat de Barcelona |
---|---|
dc.contributor.author | Juliachs Milà, Mercè |
dc.contributor.author | Muñoz, C. |
dc.contributor.author | Moutinho, Cátia |
dc.contributor.author | Vidal-Bel, August |
dc.contributor.author | Condom i Mundó, Enric |
dc.contributor.author | Esteller, Manel |
dc.contributor.author | Graupera i Garcia-Milà, Mariona |
dc.contributor.author | Casanovas i Casanovas, Oriol |
dc.contributor.author | Germà Lluch, José Ramón |
dc.contributor.author | Villanueva Garatachea, Alberto |
dc.contributor.author | Viñals Canals, Francesc |
dc.date | 2018-03-22T10:43:30Z |
dc.date | 2018-03-22T10:43:30Z |
dc.date | 2014-02 |
dc.date | 2018-03-22T10:43:31Z |
dc.identifier.citation | 1078-0432 |
dc.identifier.citation | 638378 |
dc.identifier.uri | http://hdl.handle.net/2445/120991 |
dc.format | 10 p. |
dc.format | application/pdf |
dc.language.iso | eng |
dc.publisher | American Association for Cancer Research |
dc.relation | Versió postprint del document publicat a: https://doi.org/10.1158/1078-0432.CCR-13-1131 |
dc.relation | Clinical Cancer Research, 2014, vol. 20, num. 3, p. 658-667 |
dc.relation | https://doi.org/10.1158/1078-0432.CCR-13-1131 |
dc.rights | (c) American Association for Cancer Research, 2014 |
dc.rights | info:eu-repo/semantics/openAccess |
dc.subject | Malalties del testicle |
dc.subject | Tumors |
dc.subject | Càncer |
dc.subject | Resistència als medicaments |
dc.subject | Medicaments antineoplàstics |
dc.subject | Cisplatí |
dc.subject | Testis diseases |
dc.subject | Tumors |
dc.subject | Cancer |
dc.subject | Drug resistance |
dc.subject | Antineoplastic agents |
dc.subject | Cisplatin |
dc.title | The PDGFRβ-AKT pathway contributes to CDDP-acquired resistance in testicular germ cell tumors |
dc.type | info:eu-repo/semantics/article |
dc.type | info:eu-repo/semantics/acceptedVersion |
dc.description.abstract |